Biomaterial Database

Effect of some aminoglycosides upon a drug dependent Escherichia coli strain. 1975

I Gadó, and I Dumbovich

Escherichia coli Sd-4-73 drug dependent strain was sensitive to kanamycin, gentamicin and neomycin in the absence of drugs stimulating cell multiplication. This senstivity was not considerably influenced by streptomycin, while paromomycin afforded protection against both bacteriostatic and bactericidal effects. The paromomycin concentration optimum for protection was different from its concentration optimum for multiplication.

UI	MeSH Term	Description	Entries
D007612	Kanamycin	Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.	Kanamycin A,Kanamycin Sulfate,Kantrex
D008826	Microbial Sensitivity Tests	Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).	Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009153	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.	Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154	Mutation	Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.	Mutations
D009355	Neomycin	Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.	Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D009604	Nitrosoguanidines	Nitrosylated derivatives of guanidine. They are used as MUTAGENS in MOLECULAR BIOLOGY research.
D010303	Paromomycin	An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES.	Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D002452	Cell Count	The number of CELLS of a specific kind, usually measured per unit volume or area of sample.	Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002470	Cell Survival	The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.	Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004336	Drug Antagonism	Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy.	Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms

Related Publications

I Gadó, and I Dumbovich

Reversion of a streptomycin-dependent strain of Escherichia coli.

January 1970, Molecular & general genetics : MGG,

I Gadó, and I Dumbovich

Effect of 32P decay upon DNA synthesis by a radiation-sensitive strain of Escherichia coli.

June 1966, Journal of molecular biology,

I Gadó, and I Dumbovich

Effect of 32P decay upon RNA transcription by a radiation-sensitive strain of Escherichia coli.

February 1968, Journal of molecular biology,

I Gadó, and I Dumbovich

Transport of aminoglycosides in Escherichia coli.

May 1983, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious...,

I Gadó, and I Dumbovich

A novel multidrug resistance plasmid isolated from an Escherichia coli strain resistant to aminoglycosides.

July 2012, The Journal of antimicrobial chemotherapy,

I Gadó, and I Dumbovich

Ribosomes from a streptomycin-dependent strain of Escherichia coli.

May 1967, Journal of molecular biology,

I Gadó, and I Dumbovich

[Cytological studies on a streptomycin-dependent Escherichia coli strain].

January 1954, Zeitschrift fur Hygiene und Infektionskrankheiten; medizinische Mikrobiologie, Immunologie und Virologie,

I Gadó, and I Dumbovich

[Studies on metabolism of a streptomycin-dependent Escherichia coli strain].

January 1954, Acta physiologica Academiae Scientiarum Hungaricae,